1Irvine AD, McLean WH. Human keratin diseases: the increasing spectrum of disease and subtlety of the phenotype-genotype correlation. Br J Dermatol, 1999,140:815-828.
2Hutchison C J, Alvarez-Reyes M, Vaughan OA. Lamins in disease: why do ubiquitously expressed nuclear envelope proteins give rise to tissue-specific disease phenotypes? J Cell Sci, 2001, 114:9-19.
3A1-Chalabi A, Leigh PN. Recent advances in amyotrophic lateral sclerosis. Curt Opin Neurol,2000,13:397-405.
4Carlsson L, Thomell LE. Desmin-related myopathies in mice and man. Acta Physiol Scand, 2001,171:341-348.
5Moll R, Franke WW, Schiller DL, et al. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Ce11,1982,31:11-24.
6Fuchs E, Weber K. Intermediate filaments: structure, dynamics, function, and disease. Annu Rev Biochem, 1994,63:345-382.
7Schweizer J, Bowden PE, Coulombe PA, et al. New consensus nomenclature for mammalian keratins. J Cell Biol, 2006, 174: 169-174.
8Fuchs E. Intermediate filaments and disease: mutations that cripple cell strength. J Cell Biol, 1994,125:511-516.
9Fuchs E, Cleveland DW. A structural scaffolding of intermediate filaments in health and disease. Science,1998,279:514-519.
10Herrmann H, Hesse M, Reichenzeller M, et al. Functional complexity of intermediate filament cytoskeletons : from structure to assembly to gene ablation. Int Rev Cytol,2003 ,223 :83-175.
